In a filing, Fulgent Genetics Inc revealed its Chief Scientific Officer Gao Hanlin unloaded Company’s shares for reported $15299.0 on Jun 02 ’25. In the deal valued at $20.29 per share,754 shares were sold. As a result of this transaction, Gao Hanlin now holds 961,281 shares worth roughly $20.2 million.
Then, Xie Jian sold 1,135 shares, generating $23,030 in total proceeds. Upon selling the shares at $20.29, the President and COO now owns 371,496 shares.
Before that, Xie Jian bought 1,135 shares. Fulgent Genetics Inc shares valued at $23,030 were divested by the Officer at a price of $20.29 per share.
UBS upgraded its Fulgent Genetics Inc [FLGT] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early December with a ‘”a Neutral”‘ rating. Piper Sandler also remained covering FLGT and has decreased its forecast on December 08, 2022 with a “Neutral” recommendation from previously “an Overweight” rating. Raymond James started covering the stock on November 18, 2022. It rated FLGT as “an Outperform”.
Price Performance Review of FLGT
On Tuesday, Fulgent Genetics Inc [NASDAQ:FLGT] saw its stock jump 1.94% to $21.01. Over the last five days, the stock has gained 1.11%. Fulgent Genetics Inc shares have fallen nearly -14.38% since the year began. Nevertheless, the stocks have risen 13.75% over the past one year. While a 52-week high of $24.32 was reached on 06/11/25, a 52-week low of $14.57 was recorded on 03/04/25.
Levels Of Support And Resistance For FLGT Stock
The 24-hour chart illustrates a support level at 20.56, which if violated will result in even more drops to 20.11. On the upside, there is a resistance level at 21.38. A further resistance level may holdings at 21.75.
How much short interest is there in Fulgent Genetics Inc?
A steep rise in short interest was recorded in Fulgent Genetics Inc stocks on 2025-07-31, growing by 0.17 million shares to a total of 2.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 1.93 million shares. There was a rise of 7.95%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 25, 2022 when Credit Suisse began covering the stock and recommended ‘”an Outperform”‘ rating along with a $65 price target.
